Non-peptide Inhibitors of Proprotein Convertase Subtilisin Kexins (PCSKs)

Provides an overall review of all non-peptide PCSK inhibitors so far reported in the literature along with those identified recently for the first time and not yet published. The potential implications of these molecules as biochemical, therapeutical, or clinical agents is also discussed.